NFE2L3 and cancer: In addition, NRF3 knockdown reduced p-S6K levels in other human cancer cell lines (colon cancer DLD-1 and pancreatic cancer PK-45H cells, including H1299 cells) where NRF3 is endogenously expressed (Figure S1B).